Colon adenoma
Conditions
Interventions
carbon nanoparticles group:Endoscopic carbon nanoparticles
Control group:none
Sponsors
Gastroenterology, 900 Hospital of the Joint Logistics Team
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: 1. Be between the ages of 18-79; 2. Patients with colon advanced adenoma and early colon cancer; 3. Patients who need to undergo colonoscopy for further treatment of the disease and re-examination; 4. Voluntarily signed informed consent.
Exclusion criteria
Exclusion criteria: 1. All patients who meet the contraindications to digestive endoscopy; 2. Those who have fixed anatomical parts of the rectum (less than 12cm from the anus) and cecum; 3. Patients with a history of colorectal surgery; 4. Patients with colorectal polyposis or inflammatory bowel disease; 5. patients with advanced colorectal cancer; 6. without informed consent; 7. Pregnant women or people with intestinal obstruction; 8. Are participating in other clinical observational trials or have participated in other clinical trials within 60 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The detection rate and detection time of primary lesion scar; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection rate of adenoma;Lesion recurrence rate/residual rate;Incidence of intermittent bowel cancer;Colonoscopy time;Probability of complications under endoscopic carbon nanoparticles; | — |
Countries
China
Contacts
Public ContactWang Wen
900 Hospital of the Joint Logistics Team
Outcome results
None listed